My Watchlist

Top Indices

Nasdaq Composite

SPX

My Portfolio

MEDIFAST INC Common Stock (NY:MED)

11.38 -0.08 (-0.70%)

Official Closing Price Updated: 7:00 PM EST, Nov 14, 2025 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about MEDIFAST INC Common Stock

< Previous 1 2 3 4 5 6 7 8 Next >

7 Underappreciated Stocks With 25% Return Potential in 2024 ↗

May 30, 2024

Each of these underappreciated stocks is expected to provide 25%+ returns this year, which is reason enough to pay attention.

Via InvestorPlace

LifeMD Can Surge on Its GLP-1 Offerings

May 28, 2024

LifeMD is a leading telehealth provider that investors should take note of; the company is entering the GLP-1 market, and its stock could soar as a result

Via MarketBeat

Invest in the Underestimated: 7 Bargain Stocks Poised to Prove Wall Street Wrong ↗

May 20, 2024

These undervalued stocks to buy offer an alternative to dipping your toes back into meme stock mania. Remember how it turned out last time?

Via InvestorPlace

Medifast Continues Business Transformation, Launching National Marketing Campaign Promoting its Holistic Offering for Customers Utilizing and Considering Weight Loss Medications

May 20, 2024

From Medifast

Via Business Wire

(MED) - Analyzing Medifast's Short Interest ↗

May 13, 2024

Via Benzinga

How Is The Market Feeling About Medifast? ↗

April 26, 2024

Via Benzinga

Pocket-Sized Powerhouses: 7 Small-Cap Value Stocks Ready to Roar ↗

May 13, 2024

Small-cap value stocks offer stability and continued upside as big-name stocks soak up investor attention despite overvaluation.

Via InvestorPlace

Top 4 Defensive Stocks You'll Regret Missing This Quarter ↗

May 02, 2024

Via Benzinga

Gold Down Over 2%; 3M Profit Beats Expectations ↗

April 30, 2024

Via Benzinga

Nasdaq Dips Over 100 Points; Coca-Cola Earnings Top Views ↗

April 30, 2024

Via Benzinga

INVESTIGATION ALERT: The Schall Law Firm Announces it is Investigating Claims Against Medifast, Inc. and Encourages Investors to Contact the Firm

April 30, 2024

From Schall Law

Via GlobeNewswire

(MED) - Analyzing Medifast's Short Interest ↗

April 01, 2024

Via Benzinga

Recap: Medifast Q4 Earnings ↗

February 20, 2024

Via Benzinga

Why H&E Equipment Services Shares Are Trading Lower By Around 18%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session ↗

April 30, 2024

Via Benzinga

Dow Tumbles 200 Points; McDonald's Posts Downbeat Earnings ↗

April 30, 2024

Via Benzinga

Topics Stocks

Why Is Coursera (COUR) Stock Down 16% Today? ↗

April 30, 2024

Coursera stock is falling on Tuesday as COUR investors react to the company's lackluster guidance in its latest earnings report.

Via InvestorPlace

Why Is Medifast (MED) Stock Down 20% Today? ↗

April 30, 2024

Medifast stock is down on Tuesday after the company released mixed results for Q1 2024 alongside a weak outlook for Q2 2024.

Via InvestorPlace

Why GeneDx Shares Are Trading Higher By 37%; Here Are 20 Stocks Moving Premarket ↗

April 30, 2024

Via Benzinga

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Tuesday ↗

April 30, 2024

Our coverage for Tuesday starts with a dive into the biggest pre-market stock movers traders will want to keep an eye on today!

Via InvestorPlace

Medifast Reports Mixed Results, Joins Coursera, Chegg And Other Big Stocks Moving Lower In Tuesday's Pre-Market Session ↗

April 30, 2024

Via Benzinga

MED Stock Earnings: Medifast Misses EPS, Beats Revenue for Q1 2024 ↗

April 29, 2024

MED stock results show that Medifast missed analyst estimates for earnings per share but beat on revenue for the first quarter of 2024.

Via InvestorPlace

Medifast Announces First Quarter 2024 Financial Results

April 29, 2024

From Medifast, Inc.

Via Business Wire

Tesla, Deciphera Pharmaceuticals, Heartland Financial And Other Big Stocks Moving Higher On Monday ↗

April 29, 2024

Via Benzinga

Medifast to Announce Financial Results for the First Quarter Ended March 31, 2024

April 15, 2024

From Medifast

Via Business Wire

LifeMD Shares Come Back to Life on GLP-1 Business Growth

March 19, 2024

LifeMD stock is surging as the company is riding the GLP-1 trend to double-digit revenue growth and projections for 67% earnings growth in 2024

Via MarketBeat

Hey, Bottom Fishers! 3 Beaten Up Stocks to Buy for Short-Term Gains ↗

March 07, 2024

These three companies are beaten up stocks to buy, as their oversold status and solid fundamentals make them attractive picks.

Via InvestorPlace

Navigating Challenges and Investor Rewards: Nu Skin Enterprises Ensures Steady Distribution amidst Changing Profits ↗

March 06, 2024

On March 06, 2024, Nu Skin Enterprises (NYSE:NUS) will distribute a dividend payout of $0.06 per share, equating to an annualized dividend yield of 1.38%. Shareholders who owned the stock before the...

Via Benzinga

Current Analysis: Medifast ↗

February 21, 2024

Medifast Inc is a United states based company that produces, distributes and sells products concerning weight loss, weight management, and healthy living. Its share price fell about 65% from $115.31 to...

Via Talk Markets

Why International Flavors & Fragrances Shares Are Trading Lower By Around 8%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session ↗

February 21, 2024

Shares of International Flavors & Fragrances Inc. (NYSE: IFF) fell during Wednesday’s session after the company reported mixed fourth-quarter financial results and reduced its expected quarterly...

Via Benzinga

Palo Alto Networks Issues Weak Outlook, Joins Teladoc Health, SolarEdge Technologies And Other Big Stocks Moving Lower In Wednesday's Pre-Market Session ↗

February 21, 2024

U.S. stock futures were lower this morning, with the Dow futures trading lower by around 70 points on Wednesday.

Via Benzinga

Topics Stocks

< Previous 1 2 3 4 5 6 7 8 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.